FDA has issued setting temporary rules on a probable cancer-causing impurity formerly regulated. To avoid market shortage of Losartan, drugmakers will be able to make losartan with an impurity percentage above its prescribed level for six months while the supply of clean drugs is ramped up. A calculated risk, to preserve blood pressure drugs availability […]
PQE Group is glad to announce the opening of the new office in the city of Hyderabad (Telangana), India. Grand opening for the second office in India. The grand opening ceremony took place on April 16th 2019, in the presence of PQE Group management representatives: our C.E.O. Gilda D’Incerti, the C.O.O. Claudio Puglisi, PQE India […]
Blockchain is an increasingly widespread technology that is approaching a stage of maturity that could see an explosion of its use also in the health sector. The point of the situation has been published in “Blockchain in Healthcare Today (BHTY)”, which identifies the ten main trends of this evolution. Consolidation of startups and user education […]
On the occasion of the second edition of “Italy generates future”, an event organized at the Palazzo Mezzanotte, was published by L’Economia, the financial weekly magazine of “Il Corriere della Sera”, the ranking of the 500 Italian companies that have distinguished themselves in 2017 for their profitability. Among these also PQE Group, the Tuscan consulting […]
Yes it is! Recently the U.S. Food and Drug Administration (FDA) has determined that there is credible evidence to support a qualified health claim that consuming oleic acid in edible oils, such as olive oil, sunflower oil, or canola oil, may reduce the risk of coronary heart disease. For this reason FDA decided to exercise […]
PDA Italy Chapter has chosen the new Chief Operating Officer of PQE Group, Claudio Puglisi, as a member of the executive committee for the role of Chapter Liaison and External Relationship. Claudio Puglisi joined the PDA in 1998 as a member and has distinguished himself over the years thanks to his participation in International conferences […]
European Medicines Agency (EMA), has published its draft of ‘Regulatory Science to 2025’ strategy for a six-month public consultation, following the workshop organized last October. This “Reflection Paper” is a proposed plan for advancing the Agency’s engagement with regulatory science over the next five to ten years, covering both human and veterinary medicines. The strategy will […]
Gilda D’incerti, CEO of PQE Group has been appointed as Ambassador of the Territory for the Tuscany Region, for having actively contributed in stimulating the development and cohesion of the community, developing an idea of original and authentic future, without ever losing contact with the roots of the place. On the occasion of the ceremony […]
PQE awarded at Palazzo Montecitorio (Rome, Italy) with the Special Mention.
Last 5th November PQE Group celebrated its birthday: 20 years of growth for a small company born in the countryside of Florence from the will of few people that have believed in it and that today represents one of the best Italian SMEs in the field of the pharma quality consultancy and Data Integrity Assurance. […]